Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In these highlights from the ClinicalThought program, Sara Hurvitz, MD, FACP; Joyce O’Shaughnessy, MD; and Sara Tolaney, MD, MPH, discuss key findings in breast cancer presented at the 2019 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) across multiple settings, including HER2-positive disease and hormone receptor (HR)–positive/HER2-negative breast cancer, along with chemotherapy-based treatment strategies.
CCO plans to measure the educational impact of this activity, and some questions in this activity will be asked twice: once prior to the discussion that informs the best choice and then once again after that specific discussion. Your responses will be aggregated for analysis, and your specific responses will not be shared.
Before continuing with this educational activity, please take a moment to answer the following questions.